Production (Stage)
Yubo International Biotech Limited
YBGJ
$0.0612
$0.015233.04%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -46.02% | -48.55% | -248.89% | -72.99% | -33.19% |
| Total Depreciation and Amortization | -20.09% | -3.58% | 196.30% | 471.08% | 618.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 118.63% | -- | -- | -168.06% | 31.63% |
| Change in Net Operating Assets | 53.53% | -85.46% | 230.91% | 180.18% | -91.19% |
| Cash from Operations | -55.20% | -109.46% | -34.88% | -31.21% | -51.46% |
| Capital Expenditure | 167.20% | -- | -- | -- | -296.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 200.00% | -- | -- | 100.00% | 72.11% |
| Cash from Investing | 574.33% | -- | -- | 306.03% | 0.66% |
| Total Debt Issued | 37.09% | 66.66% | 42.84% | 42.84% | 42.84% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 182.24% | -- | -- | -- | -- |
| Cash from Financing | 50.58% | 116.90% | 87.34% | 83.55% | 57.49% |
| Foreign Exchange rate Adjustments | -518.80% | -911.89% | -268.27% | -245.60% | -38.99% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -275.46% | 105.93% | 103.31% | 108.31% | 35.86% |